U.S. markets open in 8 hours

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.0300-0.0700 (-6.36%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close1.1000
Open1.1000
Bid0.0000 x 28000
Ask0.0000 x 4000
Day's Range1.0300 - 1.0927
52 Week Range0.3800 - 2.3400
Volume3,988,468
Avg. Volume8,201,246
Market Cap153.353M
Beta (5Y Monthly)1.32
PE Ratio (TTM)N/A
EPS (TTM)-0.6370
Earnings DateAug 16, 2021 - Aug 20, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Are Options Traders Betting on a Big Move in Adamis Pharmaceuticals (ADMP) Stock?
    Zacks

    Are Options Traders Betting on a Big Move in Adamis Pharmaceuticals (ADMP) Stock?

    Investors need to pay close attention to Adamis Pharmaceuticals (ADMP) stock based on the movements in the options market lately.

  • Business Wire

    Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders

    SAN DIEGO, Jun 14, 2021--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission and sent the below letter to stockholders. The letter has been signed by all five members of the Company’s Board of Directors: Howard C. Birndorf, Roshawn Blunt, Dennis J. Carlo, Ph.D., David J. Marguglio and Richard C. Williams.

  • Is Adamis Pharmaceuticals Corporation (ADMP) Going to Burn These Hedge Funds?
    Insider Monkey

    Is Adamis Pharmaceuticals Corporation (ADMP) Going to Burn These Hedge Funds?

    Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow nearly 900 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]